Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 46 AL 60

Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment

He B, Wang L, Xu B, Zhang Y; Alzheimer’s Disease Neuroimaging Initiative.

Neurosci Lett. 2021 May 29;754:135765. doi: 10.1016/j.neulet.2021.135765. Epub 2021 Mar 2.

ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease

Pereira Vatanabe I, Peron R, Mantellatto Grigoli M, Pelucchi S, De Cesare G, Magalhães T, Manzine PR, Figueredo Balthazar ML, Di Luca M, Marcello E, Cominetti MR.

Int J Mol Sci. 2021 Feb 28;22(5):2416. doi: 10.3390/ijms22052416.

Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

van Oostveen WM, de Lange ECM.

Int J Mol Sci. 2021 Feb 20;22(4):2110. doi: 10.3390/ijms22042110.

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Leuzy A, Ashton NJ, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2121-2139. doi: 10.1007/s00259-021-05258-7. Epub 2021 Mar 5.

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

Ashton NJ, Leuzy A, Karikari TK, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156. doi: 10.1007/s00259-021-05253-y. Epub 2021 Mar 6.

An Introduction to Ultrasensitive Assays for Plasma Tau Detection

Ding XL, Tuo QZ, Lei P.

J Alzheimers Dis. 2021;80(4):1353-1362. doi: 10.3233/JAD-201499.

Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial

Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, Launer LJ, Detre JA, Wolk DA, Davatzikos C, Williamson JD, Pajewski NM, Bryan RN; SPRINT Research Group.

JAMA Neurol. 2021 May 1;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.

Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics

Garibotto V, Boccardi M, Chiti A, Frisoni GB.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2067-2069. doi: 10.1007/s00259-020-05116-y.

Blood tests to screen for Alzheimer's disease

Husain M.

Brain. 2021 Mar 3;144(2):355-356. doi: 10.1093/brain/awaa462.

Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease

Gjerum L, Andersen BB, Bruun M, Simonsen AH, Henriksen OM, Law I, Hasselbalch SG, Frederiksen KS.

PLoS One. 2021 Mar 12;16(3):e0248413. doi: 10.1371/journal.pone.0248413. eCollection 2021.

Therapy for Alzheimer's disease: Missing targets and functional markers?

Stoiljkovic M, Horvath TL, Hajós M.

Ageing Res Rev. 2021 Jul;68:101318. doi: 10.1016/j.arr.2021.101318. Epub 2021 Mar 9.

Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer's disease: a systematic review and meta-analysis

Ding X, Zhang S, Jiang L, Wang L, Li T, Lei P.

Transl Neurodegener. 2021 Mar 12;10(1):10. doi: 10.1186/s40035-021-00234-5.

Microglia Biomarkers in Alzheimer's Disease

Zhang PF, Hu H, Tan L, Yu JT.

Mol Neurobiol. 2021 Jul;58(7):3388-3404. doi: 10.1007/s12035-021-02348-3. Epub 2021 Mar 12.

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

Chiotis K, Dodich A, Boccardi M, Festari C, Drzezga A, Hansson O, Ossenkoppele R, Frisoni G, Garibotto V, Nordberg A.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2086-2096. doi: 10.1007/s00259-021-05277-4. Epub 2021 Mar 15.

The emerging role of exosomes in Alzheimer's disease

Zhang T, Ma S, Lv J, Wang X, Afewerky HK, Li H, Lu Y.

Ageing Res Rev. 2021 Jul;68:101321. doi: 10.1016/j.arr.2021.101321. Epub 2021 Mar 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias